Irving Kent Loh MD FACC FAHA FCCP FACP (He/Him)

[Pronunciation: LOW]

Non-Invasive Cardiology, Preventive Cardiology, Clinical Informatics

Ventura Heart Institute/Interventional Cardiology Medical Group; Chief Medical Officer and Co-Founder, INFERMEDICA; Past Chair, Technology and Innovation Committee, California Chapter, American College of Cardiology; Member, Global Initiative, Artificial Intelligence for Health/World Health Org; Senior Advisor, MOREHealth; Senior Consultant, Care Access (global decentralized clinical trials)

Join to view full profile

Ventura Heart Institute ℅ Interventional Cardiology Medical Group2230 Lynn Road, Suite 101Thousand Oaks, CA 91360
Phone+1 805-576-7533
Fax+1 818-702-0080

Dr. Loh is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Loh's full profile Already have an account?

Summary

Dr. Irving Loh is a cardiologist based in Thousand Oaks, CA, specializing in non-invasive, preventive cardiology, clinical research as well as clinical application of artificial intelligence. He completed his medical education at the University of California San Francisco School of Medicine and furthered his training with a residency in Internal Medicine there, research training at the National Heart Lung and Blood Institute at NIH, followed by a Fellowship in Cardiovascular Disease at Cedars-Sinai Medical Center. Dr. Loh holds several prominent roles, including Senior Consultant at Care Access Research and Founding Chief Medical Officer at INFERMEDICA. He is experienced in general cardiology, dyslipidemias, hypertension, echocardiography, and cardiomyopathies. His publications focus on topics such as improving representation in cardiovascular research and the application of AI in healthcare. Dr. Loh has been recognized as a Fellow by several prestigious organizations and received an Outstanding Achievement Award from the California Chapter of the American College of Cardiology in 2019.

Education & Training

Cedars-Sinai Medical CenterFellowship, Cardiovascular Disease, 1979
National Institutes of Health Clinical CenterPost-Doctoral Fellowship, Research, 1974 - 1977
University of California (San Francisco)Residency, Internal Medicine, 1974
University of California San Francisco School of MedicineClass of 1972

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

CA State Medical License 1974 - 2027
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

Fellow, American College of Physicians American College of Physicians
Fellow, American College of Chest Physicians American College of Chest Physicians
Fellow, American Heart Association (Epidemiology & Prevention) American Heart Association

Publications & Presentations

PubMed

Improving Representation of Underserved Populations in Cardiovascular Research.
Irving K Loh, Tyler E Miller, Rahul Aggarwal, Teriya M Richmond
Journal of the American Heart Association. 2025-09-16
3 citations
Advancing the care of individuals with cancer through innovation & technology: Proceedings from the cardiology oncology innovation summit 2020 and 2021.
Sherry-Ann Brown, Craig Beavers, Brenton Bauer, Richard K Cheng, Generika Berman
American Heart Journal Plus. 2024-02-01
8 citations
The potential of virtual triage AI to improve early detection, care acuity alignment, and emergent care referral of life-threatening conditions.
George A Gellert, Aleksandra Kabat-Karabon, Gabriel L Gellert, Joanna Rasławska-Socha, Stanislaw Gorski
Frontiers in Public Health. 2024-01-01

Journal Articles

Improving Representation of Underserved Populations in Cardiovascular Research
Irving K Loh, Tyler E Miller, Rahul Aggarwal, Teriya M Richmond, Journal of the American Heart Association, 9/11/2025
Moexipril Versus Captopril in Patients with Mild to Moderate Hypertension.
M Stimpel, B Koch, T Jansen, A Fox, I Loh, J Cardiovasc Pharmacol
Effect of Amlodipine on Morbidity and Mortality in Severe Chronic Heart Failure.
Prospective Randomized Amlodipine Survival Evaluation Study Group (PRAISE), New England Journal of Medicine

Abstracts/Posters

Moexipril Versus Captopril in Patients with Mild to Moderate Hypertension.
Loh IK, Tenth Scientific Meeting of the American Society of Hypertension; New York Hilton/Towers, New York, NY

Lectures

Cardiovascular Clinical Trials.
Desert Hospital, Palm Springs, California
Randomized Clinical Trials in the Evaluation of Cardiovascular Therapies.
Syntex Corporation; Palo Alto, CA
Faculty, Symposium on the Management of High-Risk Patients.
Cedars-Sinai Medical Center; Century Plaza Hotel; Century City, CA

Other

Risk Factors in Premature Coronary Disease (Interview by Deborah Norville)
Loh IK, Guest
NBC Studios, New York
Radio Interview: Health Care Reform: Initiatives to reduce federal impediments to the delivery of health care.
Loh IK
The White House, Washington
Innovations in pharmaceuticals
IK Loh, Street Journal
http://online.wsj.com/article/

Authored Content

ACC 2021: Convergence of Cardiovascular and Diabetic Therapies ContinueMay 2021
Here's What ISCHEMIA Really MeansNovember 2019
Here's What ISCHEMIA Really MeansNovember 2019

Press Mentions

Dr. Loh: Breaking down the New High Blood Pressure GuidelinesSeptember 27th, 2025
Dr. Loh: Medications and Pills for Weight LossMay 27th, 2023
Tuesday, Jan 31 2023January 31st, 2023

Committees

Chair, Technology & Innovation Committee, California Chapter of American College of Cardiology 2019 - Present
Member, Artificial Intelligence for Symptom Assessment; International Telecommunication Union; World Health Organization 2019 - Present
Member, Executive Steering Committee of the National Health Policy Council 1993 - 1995
Member, Amgen’s Institutional BioSafety Committee
Member, State of California Department of Health Services Cardiovascular Disease Prevention Coalition

Research History

Senior Consultant/Principal Investigator- CARE ACCESS RESEARCH2023 - Present
Director & Principal InvestigatorVentura Heart Institute1985 - Present
Principal InvestigatorCardiovascular trials for Westlake Medical Research2010 - 2017
National Heart, Lung and Blood Institute at the National Institutes of Health (NIH)Intramural (Molecular Diseases/Lipid Metabolism Branch) and extramural (Cardiac Diseases Branch; Division of Heart and Vascular Diseases) divisions1974 - 1977